Growth Metrics

Ocugen (OCGN) EBITDA Margin (2020 - 2025)

Ocugen (OCGN) has disclosed EBITDA Margin for 7 consecutive years, with 9172.54% as the latest value for Q4 2025.

  • For the quarter ending Q4 2025, EBITDA Margin rose 1098602.0% year-over-year to 9172.54%, compared with a TTM value of 1537.12% through Dec 2025, down 20479.0%, and an annual FY2025 reading of 1537.12%, down 20479.0% over the prior year.
  • EBITDA Margin was 9172.54% for Q4 2025 at Ocugen, up from 1141.84% in the prior quarter.
  • Across five years, EBITDA Margin topped out at 129760.0% in Q2 2021 and bottomed at 4756.29% in Q2 2023.
  • Average EBITDA Margin over 5 years is 7889.87%, with a median of 1158.8% recorded in 2024.
  • The sharpest move saw EBITDA Margin surged 13816465bps in 2021, then plummeted -13278659bps in 2022.
  • Year by year, EBITDA Margin stood at 129760.0% in 2021, then tumbled by -102bps to 2496.36% in 2022, then surged by 69bps to 779.06% in 2023, then plummeted by -133bps to 1813.48% in 2024, then soared by 606bps to 9172.54% in 2025.
  • Business Quant data shows EBITDA Margin for OCGN at 9172.54% in Q4 2025, 1141.84% in Q3 2025, and 1075.53% in Q2 2025.